Cancer Genetics, Cell Biology, Developmental Biology, Embryology, Genetics, Growth Factors and Receptors, Human Genetics and Genetic Disorders, Knockout Mice, Oncogenes, Organogenesis, Protein Kinases, Skeletal Biology, Stem Cells, Transgenic Mice
Cancer Biology [CAB], Developmental and Stem Cell Biology [DSCB], Neuroscience [NEU]
PhD, University of Paris
Postdoctoral, Whitehead Institute, Massachusetts Institute of Technology
EnglishDownload the CV
Edwin G. Conklin Medal, Society for Developmental Biology
Society for Developmental Biology
Editor, Developmental Biology
NIH MERIT Award
Pew Scholar in the Biomedical Sciences
Assistant Investigator, Howard Hughes Medical Institute
Howard Hughes Medical Institute
Fantauzzo KA, Soriano P. PDGFRβ regulates craniofacial development through homodimers and functional heterodimers with PDGFRα. Genes & Development 2016; 30(2443-2458).
Brewer JR, Mazot P, Soriano P. Genetic insights into the mechanisms of Fgf signaling [review]. Genes & Development 2016; 30: 751-771.
Brewer JR, Molotkov A, Mazot P, Hoch RV, Soriano P. Fgfr1 regulates development through the combinatorial use of signaling proteins. Genes & Development 2015; 29: 1863-1874.
Vasudevan HN, Mazot P, He F, Soriano P. Receptor tyrosine kinases modulate distinct transcriptional programs by differential usage of intracellular pathways. eLife 2015; 4: e07186.
Vasudevan HN, Soriano P. SRF Regulates Craniofacial Development through Selective Recruitment of MRTF Cofactors by PDGF Signaling. Developmental Cell 2014; 31: 332-344.
Fantauzzo KA, Soriano P. PI3K-mediated PDGFRα signaling regulates survival and proliferation in skeletal development through p53-dependent intracellular pathways. Genes & Development 2014; 28: 1005-1017.
Olson LE, Soriano P. PDGFRβ Signaling Regulates Mural Cell Plasticity and Inhibits Fat Development. Developmental Cell 2011; 20: 815-826.
Bush JO, Soriano P. Ephrin-B1 forward signaling regulates craniofacial morphogenesis by controlling cell proliferation across Eph-ephrin boundaries. Genes & Development 2010; 24: 2068-2080.
Olson LE, Soriano P. Increased PDGFRα activation disrupts connective tissue development and drives systemic fibrosis . Developmental Cell 2009; 16: 303-313.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Soriano during 2016 and/or 2017. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.